BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20698238)

  • 1. The peculiar processing of pancreatic hormone glucagon seen in traumatized patients.
    Tanjoh K; Moriya T; Kinoshita K
    Hepatogastroenterology; 2010; 57(99-100):620-4. PubMed ID: 20698238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in glucagon kinetics and processing in patients with acute pancreatitis.
    Tanjoh K; Tomita R; Ishikawa Y; Izumi T; Kinoshita K; Azuhata T
    Hepatogastroenterology; 2007 Jun; 54(76):1250-5. PubMed ID: 17629081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in glucagon processing occurring in the intestines of surgically stressed patients.
    Tanjoh K; Tomita R; Ishikawa Y; Izumi T; Utagawa S; Kinoshita K
    Hepatogastroenterology; 2007; 54(77):1462-6. PubMed ID: 17708277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peculiar processing of glucagon and glucagon-related peptides in patients after pancreatectomy.
    Tanjoh K; Tomita R; Hayashi N
    Hepatogastroenterology; 2002; 49(45):825-32. PubMed ID: 12064000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peculiar glucagon processing in the intestine is the genesis of the paradoxical rise of serum pancreatic glucagon in patients after total pancreatectomy.
    Tanjoh K; Tomita R; Fukuzawa M; Hayashi N
    Hepatogastroenterology; 2003; 50(50):535-40. PubMed ID: 12749267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.
    Orskov C; Jeppesen J; Madsbad S; Holst JJ
    J Clin Invest; 1991 Feb; 87(2):415-23. PubMed ID: 1991827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
    Blache P; Kervran A; Bataille D
    Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.
    Ghatei MA; Uttenthal LO; Bryant MG; Christofides ND; Moody AJ; Bloom SR
    Endocrinology; 1983 Mar; 112(3):917-23. PubMed ID: 6822217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract.
    Ghatei MA; Uttenthal LO; Christofides ND; Bryant MG; Bloom SR
    J Clin Endocrinol Metab; 1983 Sep; 57(3):488-95. PubMed ID: 6874888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
    Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
    Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting and postprandial plasma glucagon and glucagon-like immunoreactivity are normal in obese Pima Indians.
    Vasquez B; Nagulesparan M; Unger RH
    Horm Metab Res; 1983 May; 15(5):218-20. PubMed ID: 6347855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
    Drucker DJ; Asa SL; Silverberg J; Brubaker PL
    Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma glucagon-immunoreactive components in early life in dogs.
    Ghiglione M; Pascual JM; Rovira A; Calvo G; Valverde I
    Horm Metab Res; 1985 Aug; 17(8):387-90. PubMed ID: 2865202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Diabetologia; 1986 Jun; 29(6):397-401. PubMed ID: 3527839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glicentin 1-61 probably represents a major fraction of glucagon-related peptides in plasma of anaesthetized uraemic pigs.
    Baldissera FG; Holst JJ
    Diabetologia; 1986 Jul; 29(7):462-7. PubMed ID: 3743926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma glicentin in diabetic and gastrectomized patients.
    Naito H; Ohneda A; Kojima R; Sato T; Sasaki K; Funayama Y; Fukushima K; Shibata C; Matsuno S; Sasaki I
    Regul Pept; 1999 Jan; 79(1):55-61. PubMed ID: 9930583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pancreatic glucagon (IRG), enteroglucagon (EG)].
    Kawabe K; Ito T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():493-5. PubMed ID: 16149559
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoreactive glucagon and insulin C-peptide in man after resection of the pancreas and total pancreatectomy.
    Kåresen R; Tronier B; Aune S
    Am J Surg; 1980 Aug; 140(2):272-6. PubMed ID: 6996505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pancreatic glucagon (IRG), enteroglucagon (EG)].
    Kawabe K; Ito T
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():529-32. PubMed ID: 20960825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.